EODData

MEMBERSHIP REGISTER LOG IN

FRA, QIA: QIAGEN NV

10 Nov 2025
LAST:

37.54

CHANGE:
 0.50		OPEN:
37.58		HIGH:
37.58		ASK:
0.00		VOLUME:
32
CHG(%):
1.35		PREV:
37.04		LOW:
37.54		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 2537.5837.5837.5437.5432
07 Nov 2537.2537.5037.0037.041.4K
06 Nov 2538.2138.2137.2437.24273
05 Nov 2538.2738.3338.1038.101.1K
04 Nov 2539.0940.0039.0240.00265
03 Nov 2540.8340.8339.4339.43789
31 Oct 2539.8640.6439.8640.64111
30 Oct 2540.6040.7039.9539.9565
29 Oct 2541.0541.0541.0041.00229
28 Oct 2541.2941.7441.2941.43441

COMPANY PROFILE

Name:QIAGEN NV
About:Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Sector:Healthcare
Address:Hulsterweg 82, Venlo, Netherlands, 5912 PL
Website:https://www.qiagen.com
ISIN:NL0015002CX3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:26.69 
Forward P/E:18.33 
PEG Ratio:-0.18 
Price to Sales:4.28 
Price to Book:2.43 
Profit Margin:0.18 
Operating Margin:0.25 
Return on Assets:0.09 
Return on Equity:0.11 
DivYield:0.01 
Div/Share:0.25 
Revenue:1.771B 
EBITDA:673.69M 
Shares:216.83M 
Market Cap:8.139B 

TECHNICAL INDICATORS

MA5:37.981.2%
MA10:39.234.5%
MA20:40.337.5%
MA50:39.755.9%
MA100:40.718.5%
MA200:39.374.9%
STO9:12.45 
STO14:9.19 
RSI14:28.40 
WPR14:-90.74 
MTM14:-4.47
ROC14:-0.11 
ATR:0.81 
Week High:40.838.8%
Week Low:37.001.4%
Month High:42.4813.2%
Month Low:37.004.9%
Year High:46.3523.5%
Year Low:32.5815.2%

RECENT SPLITS

Date Ratio
29 Jan 202535-36
30 Jan 202424.25-25
25 Jan 201726-27
14 Jul 20004-1

RECENT DIVIDENDS

Date Amount
02 Jul 2025$0.21
29 Jan 2025$1.14
30 Jan 2024$1.13
29 Jan 2024$1.32